Delivery Order SPE2DB20D1004-SPE2DB25FNHPE

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,156.29 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, with a performance period through May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.77 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,359.70, is a delivery order for the supply of 4568239340 - ISOTRETINOIN 40 MG CAPSULE 30S. The contract is a firm fixed-price, non-set-aside award with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order with a ceiling value of $1,978.20, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, with a completion date of June 6, 2025. The contract is a Firm Fixed Price arrangement and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,678.92 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a medication used to treat certain types of severe acne. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,761.24 firm fixed-price delivery order contract is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a medication used to treat certain skin conditions. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S. The contract, valued at $8,440.66, was awarded on June 4, 2025 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $2,937.58 and a period of performance extending through May 20, 2025. The contract is not set aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,229.28 firm-fixed-price delivery order is for the supply of 4,568,246,694 units of the medication isotretinoin 40 mg capsules. The contract is not set aside and has a period of performance extending through May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a $1,412.70 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a completion date of May 22, 2025. The contract is a firm fixed-price type and is not set-aside. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNHPE
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,694.43 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a prescription medication. The contract has a period of performance extending through June 9, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award described is not set-aside and is part of this larger IDC with the DLA.

Generated 9/5/25, 9:53 AM